FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

11652002: Vasoactive intestinal peptide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
20132013 Vasoactive intestinal peptide en Synonym Active Entire term case insensitive SNOMED CT core module
679274013 Vasoactive intestinal peptide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1220298013 VIP - Vasoactive intestinal polypeptide en Synonym Active Entire term case sensitive SNOMED CT core module
1220299017 Vasoactive intestinal polypeptide en Synonym Active Entire term case insensitive SNOMED CT core module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vasoactive intestinal peptide Is a Peptide hormones and their metabolites and precursors false Inferred relationship Existential restriction modifier
Vasoactive intestinal peptide Is a Gastrointestinal hormone true Inferred relationship Existential restriction modifier
Vasoactive intestinal peptide Has disposition Hormone true Inferred relationship Existential restriction modifier
Vasoactive intestinal peptide Is a Peptide hormone true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Vasoactive intestinal polypeptide measurement Has measured component False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Vasoactive intestinal polypeptide measurement Component True Vasoactive intestinal peptide Inferred relationship Existential restriction modifier 1
Aviptadil Is a True Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Measurement of vasoactive intestinal polypeptide in plasma specimen (procedure) Component True Vasoactive intestinal peptide Inferred relationship Existential restriction modifier 2
Measurement of vasoactive intestinal polypeptide in plasma specimen (procedure) Component False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Substance concentration of vasoactive intestinal peptide in plasma (observable entity) Component True Vasoactive intestinal peptide Inferred relationship Existential restriction modifier 1
Mass concentration of vasoactive intestinal polypeptide in serum (observable entity) Component True Vasoactive intestinal peptide Inferred relationship Existential restriction modifier 1
Mass concentration of vasoactive intestinal peptide in serum (observable entity) Component True Vasoactive intestinal peptide Inferred relationship Existential restriction modifier 1
Mass concentration of vasoactive intestinal peptide in plasma (observable entity) Component True Vasoactive intestinal peptide Inferred relationship Existential restriction modifier 1
Phentolamine 1mg/0.35ml / Aviptadil 25micrograms/0.35ml solution for injection ampoules Has active ingredient False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Phentolamine 2mg/0.35ml / Aviptadil 25micrograms/0.35ml solution for injection ampoules Has active ingredient False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Invicorp 1 solution for injection (Senetek Plc) Has active ingredient False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Invicorp 2 solution for injection (Senetek Plc) Has active ingredient False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Phentolamine 1mg/0.35ml / Aviptadil 25micrograms/0.35ml solution for injection ampoules 1 ampoule Has active ingredient False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Phentolamine 2mg/0.35ml / Aviptadil 25micrograms/0.35ml solution for injection ampoules 10 ampoule Has active ingredient False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Invicorp 1 solution for injection (Senetek Plc) 1 ampoule Has active ingredient False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier
Invicorp 2 solution for injection (Senetek Plc) 10 ampoule 10 x 1ml ampoules Has active ingredient False Vasoactive intestinal peptide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start